ICD-10 Coding for Endometrial Adenocarcinoma(C53.9, C53.9U, C54.1)
Comprehensive guide on ICD-10 coding for endometrial adenocarcinoma, including documentation requirements and common coding pitfalls.
Complete code families applicable to Endometrial Adenocarcinoma
Key Information
Essential facts and insights aboutEndometrial Adenocarcinoma
Alternative codes to consider when ruling out similar conditions
Use p16 and ER/PR markers to differentiate endometrial from endocervical adenocarcinoma.
Documentation & Coding Risks
Avoid these common issues when documenting Endometrial Adenocarcinoma.
Omitting histologic grade in documentation
Impact
Clinical: Impacts treatment decisions and prognosis estimation., Regulatory: Non-compliance with cancer registry reporting standards., Financial: Potential for incorrect DRG assignment.
Mitigation
Use standardized reporting templates, Ensure complete pathology report review
Using C54.8 instead of C54.1 for endometrial tumors
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Potential for audit discrepancies., Data Quality: Inaccurate cancer registry data.
Mitigation
Always specify 'endometrial' origin in pathology reports.
Histologic specificity
Impact
Lack of specificity in histologic documentation can lead to audit findings.
Mitigation
Use detailed synoptic reporting for all pathology findings.